Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer.

Petrylak DP, Kantoff P, Vogelzang NJ, Mega A, Fleming MT, Stephenson JJ Jr, Frank R, Shore ND, Dreicer R, McClay EF, Berry WR, Agarwal M, DiPippo VA, Rotshteyn Y, Stambler N, Olson WC, Morris SA, Israel RJ.

Prostate. 2019 May;79(6):604-613. doi: 10.1002/pros.23765. Epub 2019 Jan 20.

PMID:
30663074
2.

Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.

Rauck RL, Slatkin NE, Stambler N, Israel RJ.

J Pain Res. 2018 Dec 24;12:139-150. doi: 10.2147/JPR.S170086. eCollection 2019.

3.

Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.

Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo VA, Mahmood S, Wong V, Jimenez C.

J Nucl Med. 2019 May;60(5):623-630. doi: 10.2967/jnumed.118.217463. Epub 2018 Oct 5.

4.

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.

Noto RB, Pryma DA, Jensen J, Lin T, Stambler N, Strack T, Wong V, Goldsmith SJ.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):213-220. doi: 10.1210/jc.2017-02030.

PMID:
29099942
5.

Phase 2 Study of 99mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection.

Goffin KE, Joniau S, Tenke P, Slawin K, Klein EA, Stambler N, Strack T, Babich J, Armor T, Wong V.

J Nucl Med. 2017 Sep;58(9):1408-1413. doi: 10.2967/jnumed.116.187807. Epub 2017 Mar 16.

6.

Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.

Rauck R, Slatkin NE, Stambler N, Harper JR, Israel RJ.

Pain Pract. 2017 Jul;17(6):820-828. doi: 10.1111/papr.12535. Epub 2017 Feb 10.

PMID:
27860208
7.

Upgrading Marine Ecosystem Restoration Using Ecological-Social Concepts.

Abelson A, Halpern BS, Reed DC, Orth RJ, Kendrick GA, Beck MW, Belmaker J, Krause G, Edgar GJ, Airoldi L, Brokovich E, France R, Shashar N, de Blaeij A, Stambler N, Salameh P, Shechter M, Nelson PA.

Bioscience. 2016 Feb 1;66(2):156-163. Epub 2015 Dec 16.

8.

The ocean sampling day consortium.

Kopf A, Bicak M, Kottmann R, Schnetzer J, Kostadinov I, Lehmann K, Fernandez-Guerra A, Jeanthon C, Rahav E, Ullrich M, Wichels A, Gerdts G, Polymenakou P, Kotoulas G, Siam R, Abdallah RZ, Sonnenschein EC, Cariou T, O'Gara F, Jackson S, Orlic S, Steinke M, Busch J, Duarte B, Caçador I, Canning-Clode J, Bobrova O, Marteinsson V, Reynisson E, Loureiro CM, Luna GM, Quero GM, Löscher CR, Kremp A, DeLorenzo ME, Øvreås L, Tolman J, LaRoche J, Penna A, Frischer M, Davis T, Katherine B, Meyer CP, Ramos S, Magalhães C, Jude-Lemeilleur F, Aguirre-Macedo ML, Wang S, Poulton N, Jones S, Collin R, Fuhrman JA, Conan P, Alonso C, Stambler N, Goodwin K, Yakimov MM, Baltar F, Bodrossy L, Van De Kamp J, Frampton DM, Ostrowski M, Van Ruth P, Malthouse P, Claus S, Deneudt K, Mortelmans J, Pitois S, Wallom D, Salter I, Costa R, Schroeder DC, Kandil MM, Amaral V, Biancalana F, Santana R, Pedrotti ML, Yoshida T, Ogata H, Ingleton T, Munnik K, Rodriguez-Ezpeleta N, Berteaux-Lecellier V, Wecker P, Cancio I, Vaulot D, Bienhold C, Ghazal H, Chaouni B, Essayeh S, Ettamimi S, Zaid el H, Boukhatem N, Bouali A, Chahboune R, Barrijal S, Timinouni M, El Otmani F, Bennani M, Mea M, Todorova N, Karamfilov V, Ten Hoopen P, Cochrane G, L'Haridon S, Bizsel KC, Vezzi A, Lauro FM, Martin P, Jensen RM, Hinks J, Gebbels S, Rosselli R, De Pascale F, Schiavon R, Dos Santos A, Villar E, Pesant S, Cataletto B, Malfatti F, Edirisinghe R, Silveira JA, Barbier M, Turk V, Tinta T, Fuller WJ, Salihoglu I, Serakinci N, Ergoren MC, Bresnan E, Iriberri J, Nyhus PA, Bente E, Karlsen HE, Golyshin PN, Gasol JM, Moncheva S, Dzhembekova N, Johnson Z, Sinigalliano CD, Gidley ML, Zingone A, Danovaro R, Tsiamis G, Clark MS, Costa AC, El Bour M, Martins AM, Collins RE, Ducluzeau AL, Martinez J, Costello MJ, Amaral-Zettler LA, Gilbert JA, Davies N, Field D, Glöckner FO.

Gigascience. 2015 Jun 19;4:27. doi: 10.1186/s13742-015-0066-5. eCollection 2015.

9.

Depth dependent metatranscriptomes of the marine pico-/nanoplanktonic communities in the Gulf of Aqaba/Eilat during seasonal deep mixing.

Pfreundt U, Miller D, Adusumilli L, Stambler N, Berman-Frank I, Hess WR.

Mar Genomics. 2014 Dec;18 Pt B:93-5. doi: 10.1016/j.margen.2014.06.005. Epub 2014 Jun 28.

PMID:
24984262
10.

Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.

Anissian L, Schwartz HW, Vincent K, Vincent HK, Carpenito J, Stambler N, Ramakrishna T.

J Hosp Med. 2012 Feb;7(2):67-72. doi: 10.1002/jhm.943. Epub 2011 Oct 13.

PMID:
21998076
11.

Seawater quality and microbial communities at a desalination plant marine outfall. A field study at the Israeli Mediterranean coast.

Drami D, Yacobi YZ, Stambler N, Kress N.

Water Res. 2011 Nov 1;45(17):5449-62. doi: 10.1016/j.watres.2011.08.005. Epub 2011 Aug 11.

PMID:
21889185
12.

Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.

Lipman AG, Karver S, Cooney GA, Stambler N, Israel RJ.

J Pain Palliat Care Pharmacother. 2011;25(2):136-45. doi: 10.3109/15360288.2011.573531.

PMID:
21657861
13.

Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials.

Yu CS, Chun HK, Stambler N, Carpenito J, Schulman S, Tzanis E, Randazzo B.

Dis Colon Rectum. 2011 May;54(5):570-8. doi: 10.1007/DCR.0b013e3182092bde.

PMID:
21471758
14.

Is dinitrogen fixation significant in the Levantine Basin, East Mediterranean Sea?

Yogev T, Rahav E, Bar-Zeev E, Man-Aharonovich D, Stambler N, Kress N, Béjà O, Mulholland MR, Herut B, Berman-Frank I.

Environ Microbiol. 2011 Apr;13(4):854-71. doi: 10.1111/j.1462-2920.2010.02402.x. Epub 2011 Jan 18.

PMID:
21244595
15.

Phase 2a study of the CCR5 monoclonal antibody PRO 140 administered intravenously to HIV-infected adults.

Jacobson JM, Lalezari JP, Thompson MA, Fichtenbaum CJ, Saag MS, Zingman BS, D'Ambrosio P, Stambler N, Rotshteyn Y, Marozsan AJ, Maddon PJ, Morris SA, Olson WC.

Antimicrob Agents Chemother. 2010 Oct;54(10):4137-42. doi: 10.1128/AAC.00086-10. Epub 2010 Jul 26.

16.

Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.

Jacobson JM, Thompson MA, Lalezari JP, Saag MS, Zingman BS, D'Ambrosio P, Stambler N, Rotshteyn Y, Marozsan AJ, Maddon PJ, Morris SA, Olson WC.

J Infect Dis. 2010 May 15;201(10):1481-7. doi: 10.1086/652190.

17.

Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.

Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R.

J Support Oncol. 2009 Jan-Feb;7(1):39-46.

PMID:
19278178
18.

Methylnaltrexone for opioid-induced constipation in advanced illness.

Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ.

N Engl J Med. 2008 May 29;358(22):2332-43. doi: 10.1056/NEJMoa0707377.

19.

Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.

Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ.

J Pain Symptom Manage. 2008 May;35(5):458-68. doi: 10.1016/j.jpainsymman.2007.12.005.

PMID:
18440447
20.

Adaptation and spectral tuning in divergent marine proteorhodopsins from the eastern Mediterranean and the Sargasso Seas.

Sabehi G, Kirkup BC, Rozenberg M, Stambler N, Polz MF, Béjà O.

ISME J. 2007 May;1(1):48-55.

PMID:
18043613
21.

Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.

Rosow CE, Gomery P, Chen TY, Stefanovich P, Stambler N, Israel R.

Clin Pharmacol Ther. 2007 Jul;82(1):48-53. Epub 2007 Mar 28.

PMID:
17392726
22.

Differential gene expression in Symbiodinium microadriaticum clade B following stress.

Karako-Lampert S, Hershkovits G, Stambler N, Simon-Blecher N, Achituv Y, Dubinsky Z, Katcoff DJ.

Mar Biotechnol (NY). 2006 May-Jun;8(3):268-74. Epub 2006 Apr 18.

PMID:
16614872
23.

Diel 'tuning' of coral metabolism: physiological responses to light cues.

Levy O, Achituv Y, Yacobi YZ, Dubinsky Z, Stambler N.

J Exp Biol. 2006 Jan;209(Pt 2):273-83.

24.

Neurotrophin-3 improves functional constipation.

Parkman HP, Rao SS, Reynolds JC, Schiller LR, Wald A, Miner PB, Lembo AJ, Gordon JM, Drossman DA, Waltzman L, Stambler N, Cedarbaum JM; Functional Constipation Study Investigators.

Am J Gastroenterol. 2003 Jun;98(6):1338-47.

PMID:
12818279
25.

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.

Ettinger MP, Littlejohn TW, Schwartz SL, Weiss SR, McIlwain HH, Heymsfield SB, Bray GA, Roberts WG, Heyman ER, Stambler N, Heshka S, Vicary C, Guler HP.

JAMA. 2003 Apr 9;289(14):1826-32.

PMID:
12684362
26.

Disease status and use of ventilatory support by ALS patients. BDNF Study Group.

Cedarbaum JM, Stambler N.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2001 Mar;2(1):19-22.

PMID:
11465928
27.

Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans.

Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, Cedarbaum JM.

Gastroenterology. 2000 Jul;119(1):41-50.

PMID:
10889153
28.

A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials.

Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM.

J Neurol Sci. 1999 Oct 31;169(1-2):118-25.

PMID:
10540019
29.

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A.

J Neurol Sci. 1999 Oct 31;169(1-2):13-21.

PMID:
10540002
30.

Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat.

Cliffer KD, Siuciak JA, Carson SR, Radley HE, Park JS, Lewis DR, Zlotchenko E, Nguyen T, Garcia K, Tonra JR, Stambler N, Cedarbaum JM, Bodine SC, Lindsay RM, DiStefano PS.

Ann Neurol. 1998 Jan;43(1):46-55.

PMID:
9450768
31.

Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group.

Stambler N, Charatan M, Cedarbaum JM.

Neurology. 1998 Jan;50(1):66-72.

PMID:
9443459
32.
33.

Premenstrual mood changes. Characteristic patterns in women with and without premenstrual syndrome.

Rubinow DR, Roy-Byrne P, Hoban MC, Grover GN, Stambler N, Post RM.

J Affect Disord. 1986 Mar-Apr;10(2):85-90.

PMID:
2941472
34.

Experience with a new amino acid solution (Neopham) in general surgical patients.

Soroff H, Sasvary DH, Stambler NJ, Dahl S, Smith NL.

Acta Chir Scand Suppl. 1983;517:113-21. No abstract available.

PMID:
6428099

Supplemental Content

Loading ...
Support Center